Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04161781 · ClinicalTrials.gov registry record
A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 10
- Enrollment target
NCT04161781: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04161781 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04161781 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of the study is to test 18F-BMS-986229 positron emission tomography (PET) imaging a practical and safe way to check the status of esophageal, stomach, and gastroesophageal junction cancer.
Interventions
- DIAGNOSTIC_TEST PET/CT Scan
- DRUG 18F-BMS-986229 Injection
- DRUG IV 18F-BMS-986229
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2024-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04161781
The ClinicalTrials.gov registry entry for NCT04161781 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PET/CT Scan is the first listed.
NCT04161781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04161781 about?
NCT04161781 is a clinical study titled "A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer". The purpose of the study is to test 18F-BMS-986229 positron emission tomography (PET) imaging a practical and safe way to check the status of esophageal, stomach, and gastroesophageal junction cancer.
What is the current status of trial NCT04161781?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-11-12. Estimated completion is 2024-03-06.
What interventions are being tested in trial NCT04161781?
The interventions under investigation include: PET/CT Scan (DIAGNOSTIC_TEST), 18F-BMS-986229 Injection (DRUG), IV 18F-BMS-986229 (DRUG).
Who is sponsoring clinical trial NCT04161781?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.